The Venture Codex Logo

The Venture Codex

Noro-Moseley Partners

3284 Northside Parkway, NW Suite 525, Atlanta, Georgia, 30327-2337, United States

Overview

NMP is a venture capital firm that has invested in more than 200 promising start-ups and early-growth-stage companies in the technology, healthcare and business services industries. The firm is based in Atlanta, Georgia, and invests primarily in companies located throughout the United States.

Total investments
63
Lead investments
30
Investments · 12mo
2
Active investors
10

Sector focus

  • Finance
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • AvoMD

    Led · Series A · Mar 2026

    AvoMD builds a clinical AI platform designed to synthesize patient data, surface evidence-based guidance, and support clinicians with end-to-end AI copilots embedded in the EHR. The company positions its product to reduce clinician friction caused by fragmented datasets and multiple applications, aiming to drive measurable improvements in outcomes, cost savings, revenue, and operational efficiency. AvoMD announced a strategic partnership with DynaMed from EBSCO Clinical Decisions to integrate trusted evidence-based knowledge into the EHR via Ask Avo. The business emphasized clinician-centric design, saying it delivers results “with love, not alerts.” Financially, AvoMD has secured a $10M Series A to accelerate product development and commercialization. The announcement credits engaged customers, partners, and its team for supporting the company's growth.

  • Visana Health

    Led · Series A · Sep 2025

    Visana Health operates a nationwide virtual medical home for women ages 18-65, covering everything from menstruation to menopause and complex conditions such as endometriosis and PCOS. The company partners with national and regional health plans as well as more than 40 self-funded employers, extending access to over 35 million covered lives and 1 million employees. Actuarial analyses show its value-based model lowers employer medical costs by 34 %, reduces unnecessary procedures by 78 %, and saves more than $2,400 per enrollee annually, yielding a 4:1 ROI. Visana’s 50-state medical group expects to serve nearly 50,000 women in 2025. Newly raised capital will allow it to broaden services into weight loss, cardiometabolic care, and chronic disease management while investing in AI to streamline provider workflows. The company is headquartered in Minneapolis.

  • Liminal

    Led · Series A · Apr 2025

    Founded in 2022, Liminal delivers real-time, actionable intelligence through its flagship platform, Link, and its recently launched Sales Hub, which embeds market and competitive insights directly into go-to-market workflows. The company focuses on sectors such as cybersecurity, financial crime, fraud prevention, and trust & safety, translating high-volume market signals into decisions for enterprise leaders. Its solutions are already used by clients in financial services, digital identity, private equity, and other regulated industries. With a headquarters in New York City and a distributed team of researchers and technologists, Liminal combines domain expertise with scalable data infrastructure. The firm plans to expand its engineering, product, and advisory teams, deepen product capabilities, and enhance go-to-market reach using its new capital. Although specific revenue or user metrics were not disclosed, continued backing from strategic customers indicates early commercial traction. The company positions itself as replacing static PDFs and siloed dashboards with dynamic, embedded intelligence.

  • KODE

    Led · Series B · Jan 2025

    KODE operates an on-demand marketplace and the KODE Management Platform that connects hospitals and providers to a community of certified medical coders (“Koders”) while combining AI-driven tools with human expertise. The platform is designed to accelerate collections and reduce staffing costs by addressing inefficiencies in traditional medical coding workflows. KODE plans to expand its network of certified coding professionals and further develop AI and predictive-analytics capabilities to move beyond staffing into technology-first revenue cycle solutions. The company reports coding over a quarter million medical records per month and a community of more than 5,500 certified coding professionals who have coded over 8 million records to date. KODE says it has achieved consistent operational profitability. The product roadmap emphasizes additional investment in product development, platform enhancements, and scaling its team of Koders.

  • AutoScheduler.AI

    Led · Equity · Jul 2024

    AutoScheduler.AI builds a warehouse orchestration platform and WMS accelerator that sits on top of existing WMS to optimize decision-making and operations. Its core products include AutoPilot and AutoPilot Central, the latter providing a bird's-eye view of multi-site data for centralized command and control. The platform uses AI and machine learning for labor planning, inventory workflow, human-robotics interaction, and space utilization, aiming to reduce travel and inventory handling while maximizing OTIF rates and labor efficiency. AutoScheduler highlights deployments and development work with major firms, including PepsiCo, Kimberly-Clark, Unilever, and collaboration with P&G. The company plans to use new funding to enhance its AI-enabled solutions, expand through marketing and partnerships, grow the team and leadership, and bring additional AI products to market. Prior to this round, AutoScheduler was privately funded and described as growing rapidly and profitably.

Team